<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04783155</url>
  </required_header>
  <id_info>
    <org_study_id>20-012778</org_study_id>
    <nct_id>NCT04783155</nct_id>
  </id_info>
  <brief_title>Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant</brief_title>
  <official_title>Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to study the effect of training the inspiratory muscles (i.e.&#xD;
      the muscle that allow you to breath-in) on exercise capacity, quality of life, and short-term&#xD;
      clinical outcomes in patients post lung transplant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>This is a double-blinded, randomized study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal inspiratory mouth pressure (MIP) measured in cmH2O</measure>
    <time_frame>12 weeks</time_frame>
    <description>The maximal strength generating capacity of the inspiratory muscles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal oxygen uptake (V̇O2max) measured in mL/kg/min</measure>
    <time_frame>12 weeks</time_frame>
    <description>Vo2 max is the maximal measured oxygen uptake during a symptom limited exercise test.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Six-minute walk test distance (6MWTd) measured in meters (m)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Distance walked during a 6 minute test</description>
  </other_outcome>
  <other_outcome>
    <measure>Peak work rate (Wpeak) (watts)</measure>
    <time_frame>12 weeks</time_frame>
    <description>The maximal work achieved in watts during a symptom limited exercise test.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Post-Lung Transplantation Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>12-weeks pulmonary rehabilitation training plus inspiratory muscle training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To assess maximum inspiratory pressure, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>To assess maximum inspiratory pressure with placebo, you will be asked to breathe through a device called POWERBreathe Plus®. This device is commercially available and will be provided to you by the study. You will be asked to use this device twice per day, 5 days per week, for 12 weeks. Each session will require you to breathe into the device 30 times. You can use the device at home. The resistance will be set to about 5% throughout the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POWERBreathe Plus®</intervention_name>
    <description>Commercially available pressure-threshold device</description>
    <arm_group_label>12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle</arm_group_label>
    <arm_group_label>12-weeks pulmonary rehabilitation training plus inspiratory muscle training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiopulmonary rehabilitation post lung transplant</intervention_name>
    <description>Pulmonary function, lung diffusing capacity for carbon monoxide, inspiratory muscle strength, and diaphragm dimensions will be assessed in each patient. Each patient will also undergo a cardiopulmonary exercise test (CPET), 6 minute walk test, and an inspiratory muscle endurance test</description>
    <arm_group_label>12-weeks pulmonary rehabilitation plus placebo (inactive) inspiratory muscle</arm_group_label>
    <arm_group_label>12-weeks pulmonary rehabilitation training plus inspiratory muscle training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - All patients who undergo single- or double-lung transplant at Mayo Clinic Florida.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who do not survive the intra-operative period during the transplant surgery.&#xD;
&#xD;
          -  Patients undergoing retransplantation.&#xD;
&#xD;
          -  Patients undergoing multiorgan transplantation.&#xD;
&#xD;
          -  Patients who are not willing to or who are unable to give written informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bryan Taylor, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Temetria Miller</last_name>
      <phone>904-953-2000</phone>
      <email>miller.temetria@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Bryan Taylor</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Inspiratory muscle training</keyword>
  <keyword>post lung transplant</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>breathing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

